SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

12 Nov 2021 Evaluate
The revenue for the September 2021 quarter is pegged at Rs. 990.10 millions, about 6.10% up against Rs. 933.19 millions recorded during the year-ago period.Net profit of the cmpany stood at Rs. 65.66 millions for the quarter ended September 2021 a decline of -56.06% from Rs. 149.43 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 198.95 millions from 285.83 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 990.10 933.19 6.10 2078.94 1942.48 7.03 3728.22 3005.07 24.06
Other Income 23.52 9.37 151.01 34.24 22.14 54.65 66.18 123.13 -46.25
PBIDT 198.95 285.83 -30.40 485.40 547.17 -11.29 1003.36 818.05 22.65
Interest 44.44 54.72 -18.79 86.24 90.93 -5.16 180.75 193.20 -6.44
PBDT 154.51 231.11 -33.14 399.16 456.24 -12.51 822.61 624.85 31.65
Depreciation 59.75 45.41 31.58 114.37 84.16 35.90 190.31 149.38 27.40
PBT 94.76 185.70 -48.97 284.79 372.08 -23.46 632.30 475.47 32.98
TAX 29.10 36.27 -19.77 91.27 59.57 53.21 112.60 -161.24 -169.83
Deferred Tax 12.57 3.32 278.61 41.54 -7.39 -662.11 0.03 -194.89 -100.02
PAT 65.66 149.43 -56.06 193.52 312.51 -38.08 519.70 636.71 -18.38
Equity 144.24 144.24 0.00 144.24 144.24 0.00 144.24 144.24 0.00
PBIDTM(%) 20.09 30.63 -34.40 23.35 28.17 -17.11 26.91 27.22 -1.14

Fermenta Biotech Share Price

314.55 3.00 (0.96%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×